    {
      "ispublished": "pub",
      "metadata_visibility": "show",
      "date_type": "published",
      "note": "Imported from MJST Journal (OAI id oai:ojs.pkp.sfu.ca:article/3958)",
      "userid": 1,
      "subjects": [
        "Immune microthrombovasculitis, anticoagulant therapy, hemostatic parameters, D-dimer, fibrinogen, von Willebrand factor, C-reactive protein."
      ],
      "official_url": "https://mjstjournal.com/index.php/mjst/article/view/3958",
      "type": "article",
      "full_text_status": "none",
      "id_number": "oai:ojs.pkp.sfu.ca:article/3958",
      "uri": "https://arxiv.universalpublishings.com/id/eprint/60183",
      "date": "2025-06-09",
      "title": "CLINICAL DYNAMICS OF HEMOSTATIC SYSTEM PARAMETERS AND THE ROLE OF BIOMARKERS IN PATIENTS WITH IMMUNE MICROTHROMBOVASCULITIS UNDER ANTICOAGULANT THERAPY",
      "status_changed": "2026-05-26 15:51:30",
      "abstract": "Immune microthrombovasculitis (IMTV) is a rare disorder characterized by immune-mediated microvascular thrombosis, often requiring anticoagulant therapy to mitigate thrombotic complications. This prospective study investigates the dynamics of hemostatic system parameters (D-dimer, fibrinogen, prothrombin time [PT], activated partial thromboplastin time [APTT]) and biomarkers (von Willebrand factor [vWF], C-reactive protein [CRP]) in 40 patients with IMTV over a 12-month period. Patients received either warfarin or direct oral anticoagulants (DOACs). Significant reductions in D-dimer levels (from 1.3 \u00b5g/mL to 0.5 \u00b5g/mL, p&lt;0.01) and stabilization of APTT were observed in 85% of DOAC-treated patients. Fibrinogen levels remained elevated in 55% of patients, correlating with CRP (r=0.68, p&lt;0.01). Elevated vWF levels at baseline (185 IU/dL) decreased modestly (145 IU/dL, p=0.04), reflecting partial endothelial recovery. Persistent vWF elevation was associated with a 20% incidence of recurrent thrombotic events. These findings underscore the utility of hemostatic parameters and biomarkers in monitoring therapy efficacy and predicting outcomes, advocating for personalized treatment strategies in IMTV.",
      "creators": [
        {
          "name": {
            "given": "Z.Ch.",
            "honourific": null,
            "lineage": null,
            "family": "Kurbanova"
          }
        },
        {
          "name": {
            "honourific": null,
            "given": "Sayfuddinova",
            "lineage": null,
            "family": "Z.A"
          }
        },
        {
          "name": {
            "lineage": null,
            "family": "Begmatova3",
            "given": ".A.",
            "honourific": null
          }
        }
      ],
      "eprintid": 60183,
      "keywords": "Immune microthrombovasculitis, anticoagulant therapy, hemostatic parameters, D-dimer, fibrinogen, von Willebrand factor, C-reactive protein.",
      "dir": "disk0/00/06/01/83",
      "sword_depositor": 1,
      "publication": "Multidisciplinary Journal of Science and Technology",
      "lastmod": "2026-05-26 15:51:30",
      "eprint_status": "archive",
      "publisher": "Center for Tech and Media Research",
      "datestamp": "2026-05-26 15:51:30",
      "rev_number": 1
    }